Global and China GLP-1 Receptor Agonists Market Size, Status and Forecast 2021-2027
SKU ID : QYR-19203436 | Publishing Date : 22-Sep-2021 | No. of pages : 100
Detailed TOC of Global and China GLP-1 Receptor Agonists Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GLP-1 Receptor Agonists Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Exenatide
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Others
1.3 Market by Application
1.3.1 Global GLP-1 Receptor Agonists Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global GLP-1 Receptor Agonists Market Perspective (2016-2027)
2.2 GLP-1 Receptor Agonists Growth Trends by Regions
2.2.1 GLP-1 Receptor Agonists Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 GLP-1 Receptor Agonists Historic Market Share by Regions (2016-2021)
2.2.3 GLP-1 Receptor Agonists Forecasted Market Size by Regions (2022-2027)
2.3 GLP-1 Receptor Agonists Industry Dynamic
2.3.1 GLP-1 Receptor Agonists Market Trends
2.3.2 GLP-1 Receptor Agonists Market Drivers
2.3.3 GLP-1 Receptor Agonists Market Challenges
2.3.4 GLP-1 Receptor Agonists Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GLP-1 Receptor Agonists Players by Revenue
3.1.1 Global Top GLP-1 Receptor Agonists Players by Revenue (2016-2021)
3.1.2 Global GLP-1 Receptor Agonists Revenue Market Share by Players (2016-2021)
3.2 Global GLP-1 Receptor Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by GLP-1 Receptor Agonists Revenue
3.4 Global GLP-1 Receptor Agonists Market Concentration Ratio
3.4.1 Global GLP-1 Receptor Agonists Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GLP-1 Receptor Agonists Revenue in 2020
3.5 GLP-1 Receptor Agonists Key Players Head office and Area Served
3.6 Key Players GLP-1 Receptor Agonists Product Solution and Service
3.7 Date of Enter into GLP-1 Receptor Agonists Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GLP-1 Receptor Agonists Breakdown Data by Type
4.1 Global GLP-1 Receptor Agonists Historic Market Size by Type (2016-2021)
4.2 Global GLP-1 Receptor Agonists Forecasted Market Size by Type (2022-2027)
5 GLP-1 Receptor Agonists Breakdown Data by Application
5.1 Global GLP-1 Receptor Agonists Historic Market Size by Application (2016-2021)
5.2 Global GLP-1 Receptor Agonists Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America GLP-1 Receptor Agonists Market Size (2016-2027)
6.2 North America GLP-1 Receptor Agonists Market Size by Type
6.2.1 North America GLP-1 Receptor Agonists Market Size by Type (2016-2021)
6.2.2 North America GLP-1 Receptor Agonists Market Size by Type (2022-2027)
6.2.3 North America GLP-1 Receptor Agonists Market Size by Type (2016-2027)
6.3 North America GLP-1 Receptor Agonists Market Size by Application
6.3.1 North America GLP-1 Receptor Agonists Market Size by Application (2016-2021)
6.3.2 North America GLP-1 Receptor Agonists Market Size by Application (2022-2027)
6.3.3 North America GLP-1 Receptor Agonists Market Size by Application (2016-2027)
6.4 North America GLP-1 Receptor Agonists Market Size by Country
6.4.1 North America GLP-1 Receptor Agonists Market Size by Country (2016-2021)
6.4.2 North America GLP-1 Receptor Agonists Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe GLP-1 Receptor Agonists Market Size (2016-2027)
7.2 Europe GLP-1 Receptor Agonists Market Size by Type
7.2.1 Europe GLP-1 Receptor Agonists Market Size by Type (2016-2021)
7.2.2 Europe GLP-1 Receptor Agonists Market Size by Type (2022-2027)
7.2.3 Europe GLP-1 Receptor Agonists Market Size by Type (2016-2027)
7.3 Europe GLP-1 Receptor Agonists Market Size by Application
7.3.1 Europe GLP-1 Receptor Agonists Market Size by Application (2016-2021)
7.3.2 Europe GLP-1 Receptor Agonists Market Size by Application (2022-2027)
7.3.3 Europe GLP-1 Receptor Agonists Market Size by Application (2016-2027)
7.4 Europe GLP-1 Receptor Agonists Market Size by Country
7.4.1 Europe GLP-1 Receptor Agonists Market Size by Country (2016-2021)
7.4.2 Europe GLP-1 Receptor Agonists Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific GLP-1 Receptor Agonists Market Size (2016-2027)
8.2 Asia-Pacific GLP-1 Receptor Agonists Market Size by Type
8.2.1 Asia-Pacific GLP-1 Receptor Agonists Market Size by Type (2016-2021)
8.2.2 Asia-Pacific GLP-1 Receptor Agonists Market Size by Type (2022-2027)
8.2.3 Asia-Pacific GLP-1 Receptor Agonists Market Size by Type (2016-2027)
8.3 Asia-Pacific GLP-1 Receptor Agonists Market Size by Application
8.3.1 Asia-Pacific GLP-1 Receptor Agonists Market Size by Application (2016-2021)
8.3.2 Asia-Pacific GLP-1 Receptor Agonists Market Size by Application (2022-2027)
8.3.3 Asia-Pacific GLP-1 Receptor Agonists Market Size by Application (2016-2027)
8.4 Asia-Pacific GLP-1 Receptor Agonists Market Size by Region
8.4.1 Asia-Pacific GLP-1 Receptor Agonists Market Size by Region (2016-2021)
8.4.2 Asia-Pacific GLP-1 Receptor Agonists Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America GLP-1 Receptor Agonists Market Size (2016-2027)
9.2 Latin America GLP-1 Receptor Agonists Market Size by Type
9.2.1 Latin America GLP-1 Receptor Agonists Market Size by Type (2016-2021)
9.2.2 Latin America GLP-1 Receptor Agonists Market Size by Type (2022-2027)
9.2.3 Latin America GLP-1 Receptor Agonists Market Size by Type (2016-2027)
9.3 Latin America GLP-1 Receptor Agonists Market Size by Application
9.3.1 Latin America GLP-1 Receptor Agonists Market Size by Application (2016-2021)
9.3.2 Latin America GLP-1 Receptor Agonists Market Size by Application (2022-2027)
9.3.3 Latin America GLP-1 Receptor Agonists Market Size by Application (2016-2027)
9.4 Latin America GLP-1 Receptor Agonists Market Size by Country
9.4.1 Latin America GLP-1 Receptor Agonists Market Size by Country (2016-2021)
9.4.2 Latin America GLP-1 Receptor Agonists Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GLP-1 Receptor Agonists Market Size (2016-2027)
10.2 Middle East & Africa GLP-1 Receptor Agonists Market Size by Type
10.2.1 Middle East & Africa GLP-1 Receptor Agonists Market Size by Type (2016-2021)
10.2.2 Middle East & Africa GLP-1 Receptor Agonists Market Size by Type (2022-2027)
10.2.3 Middle East & Africa GLP-1 Receptor Agonists Market Size by Type (2016-2027)
10.3 Middle East & Africa GLP-1 Receptor Agonists Market Size by Application
10.3.1 Middle East & Africa GLP-1 Receptor Agonists Market Size by Application (2016-2021)
10.3.2 Middle East & Africa GLP-1 Receptor Agonists Market Size by Application (2022-2027)
10.3.3 Middle East & Africa GLP-1 Receptor Agonists Market Size by Application (2016-2027)
10.4 Middle East & Africa GLP-1 Receptor Agonists Market Size by Country
10.4.1 Middle East & Africa GLP-1 Receptor Agonists Market Size by Country (2016-2021)
10.4.2 Middle East & Africa GLP-1 Receptor Agonists Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK GLP-1 Receptor Agonists Introduction
11.1.4 GSK Revenue in GLP-1 Receptor Agonists Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk GLP-1 Receptor Agonists Introduction
11.2.4 Novo Nordisk Revenue in GLP-1 Receptor Agonists Business (2016-2021)
11.2.5 Novo Nordisk Recent Development
11.3 Lily
11.3.1 Lily Company Details
11.3.2 Lily Business Overview
11.3.3 Lily GLP-1 Receptor Agonists Introduction
11.3.4 Lily Revenue in GLP-1 Receptor Agonists Business (2016-2021)
11.3.5 Lily Recent Development
11.4 Haosoh
11.4.1 Haosoh Company Details
11.4.2 Haosoh Business Overview
11.4.3 Haosoh GLP-1 Receptor Agonists Introduction
11.4.4 Haosoh Revenue in GLP-1 Receptor Agonists Business (2016-2021)
11.4.5 Haosoh Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi GLP-1 Receptor Agonists Introduction
11.5.4 Sanofi Revenue in GLP-1 Receptor Agonists Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca GLP-1 Receptor Agonists Introduction
11.6.4 AstraZeneca Revenue in GLP-1 Receptor Agonists Business (2016-2021)
11.6.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and China GLP-1 Receptor Agonists Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global GLP-1 Receptor Agonists Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Exenatide
Table 3. Key Players of Liraglutide
Table 4. Key Players of Lixisenatide
Table 5. Key Players of Albiglutide
Table 6. Key Players of Others
Table 7. Global GLP-1 Receptor Agonists Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global GLP-1 Receptor Agonists Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global GLP-1 Receptor Agonists Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global GLP-1 Receptor Agonists Market Share by Regions (2016-2021)
Table 11. Global GLP-1 Receptor Agonists Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global GLP-1 Receptor Agonists Market Share by Regions (2022-2027)
Table 13. GLP-1 Receptor Agonists Market Trends
Table 14. GLP-1 Receptor Agonists Market Drivers
Table 15. GLP-1 Receptor Agonists Market Challenges
Table 16. GLP-1 Receptor Agonists Market Restraints
Table 17. Global GLP-1 Receptor Agonists Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global GLP-1 Receptor Agonists Market Share by Players (2016-2021)
Table 19. Global Top GLP-1 Receptor Agonists Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GLP-1 Receptor Agonists as of 2020)
Table 20. Ranking of Global Top GLP-1 Receptor Agonists Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by GLP-1 Receptor Agonists Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players GLP-1 Receptor Agonists Product Solution and Service
Table 24. Date of Enter into GLP-1 Receptor Agonists Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global GLP-1 Receptor Agonists Market Size by Type (2016-2021) (US$ Million)
Table 27. Global GLP-1 Receptor Agonists Revenue Market Share by Type (2016-2021)
Table 28. Global GLP-1 Receptor Agonists Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global GLP-1 Receptor Agonists Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global GLP-1 Receptor Agonists Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global GLP-1 Receptor Agonists Revenue Market Share by Application (2016-2021)
Table 32. Global GLP-1 Receptor Agonists Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global GLP-1 Receptor Agonists Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America GLP-1 Receptor Agonists Market Size by Type (2016-2021) (US$ Million)
Table 35. North America GLP-1 Receptor Agonists Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America GLP-1 Receptor Agonists Market Size by Application (2016-2021) (US$ Million)
Table 37. North America GLP-1 Receptor Agonists Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America GLP-1 Receptor Agonists Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America GLP-1 Receptor Agonists Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe GLP-1 Receptor Agonists Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe GLP-1 Receptor Agonists Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe GLP-1 Receptor Agonists Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe GLP-1 Receptor Agonists Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe GLP-1 Receptor Agonists Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe GLP-1 Receptor Agonists Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific GLP-1 Receptor Agonists Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific GLP-1 Receptor Agonists Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific GLP-1 Receptor Agonists Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific GLP-1 Receptor Agonists Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific GLP-1 Receptor Agonists Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific GLP-1 Receptor Agonists Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America GLP-1 Receptor Agonists Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America GLP-1 Receptor Agonists Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America GLP-1 Receptor Agonists Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America GLP-1 Receptor Agonists Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America GLP-1 Receptor Agonists Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America GLP-1 Receptor Agonists Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa GLP-1 Receptor Agonists Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa GLP-1 Receptor Agonists Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa GLP-1 Receptor Agonists Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa GLP-1 Receptor Agonists Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa GLP-1 Receptor Agonists Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa GLP-1 Receptor Agonists Market Size by Country (2022-2027) & (US$ Million)
Table 64. GSK Company Details
Table 65. GSK Business Overview
Table 66. GSK GLP-1 Receptor Agonists Product
Table 67. GSK Revenue in GLP-1 Receptor Agonists Business (2016-2021) & (US$ Million)
Table 68. GSK Recent Development
Table 69. Novo Nordisk Company Details
Table 70. Novo Nordisk Business Overview
Table 71. Novo Nordisk GLP-1 Receptor Agonists Product
Table 72. Novo Nordisk Revenue in GLP-1 Receptor Agonists Business (2016-2021) & (US$ Million)
Table 73. Novo Nordisk Recent Development
Table 74. Lily Company Details
Table 75. Lily Business Overview
Table 76. Lily GLP-1 Receptor Agonists Product
Table 77. Lily Revenue in GLP-1 Receptor Agonists Business (2016-2021) & (US$ Million)
Table 78. Lily Recent Development
Table 79. Haosoh Company Details
Table 80. Haosoh Business Overview
Table 81. Haosoh GLP-1 Receptor Agonists Product
Table 82. Haosoh Revenue in GLP-1 Receptor Agonists Business (2016-2021) & (US$ Million)
Table 83. Haosoh Recent Development
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi GLP-1 Receptor Agonists Product
Table 87. Sanofi Revenue in GLP-1 Receptor Agonists Business (2016-2021) & (US$ Million)
Table 88. Sanofi Recent Development
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca GLP-1 Receptor Agonists Product
Table 92. AstraZeneca Revenue in GLP-1 Receptor Agonists Business (2016-2021) & (US$ Million)
Table 93. AstraZeneca Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global GLP-1 Receptor Agonists Market Share by Type: 2020 VS 2027
Figure 2. Exenatide Features
Figure 3. Liraglutide Features
Figure 4. Lixisenatide Features
Figure 5. Albiglutide Features
Figure 6. Others Features
Figure 7. Global GLP-1 Receptor Agonists Market Share by Application: 2020 VS 2027
Figure 8. Solid Tumors Case Studies
Figure 9. Blood-related Tumors Case Studies
Figure 10. GLP-1 Receptor Agonists Report Years Considered
Figure 11. Global GLP-1 Receptor Agonists Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global GLP-1 Receptor Agonists Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global GLP-1 Receptor Agonists Market Share by Regions: 2020 VS 2027
Figure 14. Global GLP-1 Receptor Agonists Market Share by Regions (2022-2027)
Figure 15. Global GLP-1 Receptor Agonists Market Share by Players in 2020
Figure 16. Global Top GLP-1 Receptor Agonists Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GLP-1 Receptor Agonists as of 2020
Figure 17. The Top 10 and 5 Players Market Share by GLP-1 Receptor Agonists Revenue in 2020
Figure 18. Global GLP-1 Receptor Agonists Revenue Market Share by Type (2016-2021)
Figure 19. Global GLP-1 Receptor Agonists Revenue Market Share by Type (2022-2027)
Figure 20. North America GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America GLP-1 Receptor Agonists Market Share by Type (2016-2027)
Figure 22. North America GLP-1 Receptor Agonists Market Share by Application (2016-2027)
Figure 23. North America GLP-1 Receptor Agonists Market Share by Country (2016-2027)
Figure 24. United States GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe GLP-1 Receptor Agonists Market Share by Type (2016-2027)
Figure 28. Europe GLP-1 Receptor Agonists Market Share by Application (2016-2027)
Figure 29. Europe GLP-1 Receptor Agonists Market Share by Country (2016-2027)
Figure 30. Germany GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific GLP-1 Receptor Agonists Market Share by Type (2016-2027)
Figure 38. Asia-Pacific GLP-1 Receptor Agonists Market Share by Application (2016-2027)
Figure 39. Asia-Pacific GLP-1 Receptor Agonists Market Share by Region (2016-2027)
Figure 40. China GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America GLP-1 Receptor Agonists Market Share by Type (2016-2027)
Figure 48. Latin America GLP-1 Receptor Agonists Market Share by Application (2016-2027)
Figure 49. Latin America GLP-1 Receptor Agonists Market Share by Country (2016-2027)
Figure 50. Mexico GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa GLP-1 Receptor Agonists Market Share by Type (2016-2027)
Figure 54. Middle East & Africa GLP-1 Receptor Agonists Market Share by Application (2016-2027)
Figure 55. Middle East & Africa GLP-1 Receptor Agonists Market Share by Country (2016-2027)
Figure 56. Turkey GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE GLP-1 Receptor Agonists Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GSK Revenue Growth Rate in GLP-1 Receptor Agonists Business (2016-2021)
Figure 60. Novo Nordisk Revenue Growth Rate in GLP-1 Receptor Agonists Business (2016-2021)
Figure 61. Lily Revenue Growth Rate in GLP-1 Receptor Agonists Business (2016-2021)
Figure 62. Haosoh Revenue Growth Rate in GLP-1 Receptor Agonists Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in GLP-1 Receptor Agonists Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in GLP-1 Receptor Agonists Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Keyplayers in Global and China GLP-1 Receptor Agonists Market Size, Status and Forecast 2021-2027
GSKNovo Nordisk
Lily
Haosoh
Sanofi
AstraZeneca